Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 1
Submit an article Journal homepage
265
Views
17
CrossRef citations to date
0
Altmetric
Original Article: Clinical

The evolution of treatment strategies for patients with chronic myeloid leukemia relapsing after allogeneic bone marrow transplant: can tyrosine kinase inhibitors replace donor lymphocyte infusions?

Joshua F. ZeidnerDivision of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA
,
Marianna ZahurakDivision of Oncology Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA
,
Gary L. RosnerDivision of Oncology Biostatistics and Bioinformatics, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA
,
Christopher D. GockeDepartment of Pathology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA
,
Richard J. JonesDivision of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA
&
B. Douglas SmithDivision of Hematologic Malignancies, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USACorrespondence[email protected]
Pages 128-134 | Received 17 Jan 2014, Accepted 29 Mar 2014, Published online: 16 Jun 2014

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Evandro D. Bezerra, Mary E. Flowers, Lynn E. Onstad, Deborah Chielens, Jerald Radich & Celestia S. Higano. (2019) A phase 2 study of alpha interferon for molecularly measurable residual disease in chronic myeloid leukemia after allogeneic hematopoietic cell transplantation. Leukemia & Lymphoma 60:11, pages 2754-2761.
Read now
Salvatore Perrone, Fulvio Massaro, Giuliana Alimena & Massimo Breccia. (2016) How has treatment changed for blast phase chronic myeloid leukemia patients in the tyrosine kinase inhibitor era? A review of efficacy and safety. Expert Opinion on Pharmacotherapy 17:11, pages 1517-1526.
Read now
Joshua F. Zeidner & B. Douglas Smith. (2015) Optimizing the management of relapsed chronic myeloid leukemia post-allogeneic bone marrow transplant. Leukemia & Lymphoma 56:10, pages 3001-3002.
Read now
Ahmet Emre Eskazan, Isil Erdogan, Selin Berk, Fevzi Firat Yalniz, Tugrul Elverdi, Ayse Salihoglu & Teoman Soysal. (2015) Relapse after allogeneic hematopoietic stem cell transplant in patients with chronic myeloid leukemia: tyrosine kinase inhibitors, donor lymphocyte infusions or both?. Leukemia & Lymphoma 56:10, pages 2995-2996.
Read now

Articles from other publishers (13)

Stephanie Sembill, Maria Ampatzidou, Sonali Chaudhury, Michael Dworzak, Krzysztof Kalwak, Axel Karow, Alexander Kiani, Manuela Krumbholz, Maaike Luesink, Nora Naumann-Bartsch, Barbara De Moerloose, Michael Osborn, Kirk R. Schultz, Petr Sedlacek, Fiorina Giona, Christian Michel Zwaan, Hiroyuki Shimada, Birgitta Versluijs, Frederic Millot, Nobuko Hijiya, Meinolf Suttorp & Markus Metzler. (2023) Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations. Leukemia 37:3, pages 505-517.
Crossref
Ya-Ching Hsieh, Kristina Kirschner & Mhairi Copland. (2021) Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape. Leukemia 35:5, pages 1229-1242.
Crossref
Christoph Schmid, Jürgen Kuball & Gesine Bug. (2021) Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies. Journal of Clinical Oncology 39:5, pages 397-418.
Crossref
David Snyder. 2021. Biology and Treatment of Leukemia and Bone Marrow Neoplasms. Biology and Treatment of Leukemia and Bone Marrow Neoplasms 97 114 .
Selin Kucukyurt, Tugrul Elverdi & Ahmet Emre Eskazan. (2020) Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Myeloid Leukemia: What is the Best Strategy?. Biology of Blood and Marrow Transplantation 26:9, pages e237-e238.
Crossref
Sarah Schmidt, Ying Liu, Zhen-Huan Hu, Kirsten M. Williams, Hillard M. Lazarus, Ravi Vij, Mohamed A. Kharfan-Dabaja, Guillermo Ortí, Peter H. Wiernik, Daniel Weisdorf, Rammurti T. Kamble, Roger Herzig, Baldeep Wirk, Jan Cerny, Ulrike Bacher, Naeem A. Chaudhri, Sunita Nathan, Nosha Farhadfar, Mahmoud Aljurf, Usama Gergis, Jeffrey Szer, Sachiko Seo, Jack W. Hsu, Richard F. Olsson, Dipnarine Maharaj, Biju George, Gerhard C. Hildebrandt, Vaibhav Agrawal, Taiga Nishihori, Hisham Abdel-Azim, Edwin Alyea, Uday Popat, Ronald Sobecks, Bart L. Scott, Jennifer Holter Chakrabarty & Wael Saber. (2020) The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era. Biology of Blood and Marrow Transplantation 26:6, pages 1137-1143.
Crossref
Tobias Bluhmki, Claudia Schmoor, Jürgen Finke, Martin Schumacher, Gérard Socié & Jan Beyersmann. (2020) Relapse- and Immunosuppression-Free Survival after Hematopoietic Stem Cell Transplantation: How Can We Assess Treatment Success for Complex Time-to-Event Endpoints?. Biology of Blood and Marrow Transplantation 26:5, pages 992-997.
Crossref
Gérard Socié, Robert Zeiser & Bruce R. Blazar. 2019. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation 415 422 .
Håkon Reikvam, Jørn Skavland, Stein-Erik Gullaksen, Randi Hovland, Tobias Gedde-Dahl, Øystein Bruserud & Bjørn Tore Gjertsen. (2018) Chronic Myeloid Leukemia Relapsing 25 Years after Allogenic Stem Cell Transplantation. Case Reports in Hematology 2018, pages 1-4.
Crossref
Ahmet Emre Emre Eskazan & Mario Tiribelli. (2018) Allogeneic Haematopoietic Stem Cell Transplantation for Chronic Myeloid Leukaemia in the Era of Tyrosine Kinase Inhibitors. EMJ Hematology, pages 63-70.
Crossref
Syed A. Abutalib & Hillard M. Lazarus. 2018. Neoplastic Diseases of the Blood. Neoplastic Diseases of the Blood 1211 1245 .
. 2017. Hematopoietic Cell Transplants. Hematopoietic Cell Transplants 339 360 .
Thales Dalessandro Meneguin Pereira, Robert Danby & Vanderson Rocha. (2015) Donor lymphocyte infusion after allogeneic hematopoietic stem cell transplantation. International Journal of Hematologic Oncology 4:5, pages 201-210.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.